The stock of UnitedHealth Group Incorporated (NYSE:UNH) decreased by -$1.33 on Tuesday to $509.60, down -0.26 percent. The last five days have seen an average of 1,759,859 shares of common stock traded. 3 times new highs were reached in the current year, with a fall of -$20.25. The average number of shares traded over the last 20 days was 2,590,215, while the average volume over the last 50 days totaled 3,991,592.
UNH stock appreciated 5.27% since last month. On 07/17/23, the company’s shares reached a one-month low of $478.30. The stock touched a high of $558.10 on 04/13/23, after rallying from a low of $445.68 in 52 weeks. The price of UNH stock has declined by -3.88% or -$20.25 this year, reaching a new high 3 times. Still, the stock price is down -8.69% from the 52-week high.
Insider Transactions
UNH stock investors should be aware that UnitedHealth Group Incorporated (UNH) stock had its last reported insider trading activity 27 days ago on Jul 19. On Jul 19, CEO, UHG WITTY ANDREW sold 4,000 shares at $506.19 each. This transaction resulted in the insider making $2,024,760. On Apr 27, WITTY ANDREW sold 6,160 shares at a price of US$487.49. After the transaction, the insider now owns 86,564 shares. EVP Chief People Officer McSweeney Erin had earlier sold 761 shares on Apr 25 for $494.80 a share. The transaction was completed for $376,543.
Valuation Metrics
UnitedHealth Group Incorporated (UNH) has a trailing price-to-earnings (P/E) ratio of 22.80. Beta for the stock is 0.66. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 1.34, the price-to-book (PB) ratio of 5.75, and the price-to-cash flow ratio of 12.25.
Company paid $1.88 per share in dividends, an increase of 13.94% from $1.65 last year. A $0.23 dividend increase was reported on Wednesday June 7 2023.
Financial Health
The company’s long-term debt to equity ratio for the quarter ending June 29 is 0.72, and the total debt to equity ratio is 0.80. UnitedHealth Group Incorporated’s operating margin stood at 8.80% for the same period. Based on annual data, it had gross profit of $79.62 billion and revenue of $324.16 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. UNH’s return on assets (ROA) during the last 12 months has been 8.00%. There was a 16.80% return on investment (ROI) in the past year. In the meantime, the return on equity (ROE) for the last 12 months was 26.70%.
Earnings Surprise
According to UnitedHealth Group Incorporated’s quarterly financial report for the quarter that ended June 29. A higher net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $92.9 billion, while revenues rose by 13.53% to $91.93 billion. It was predicted that UnitedHealth Group Incorporated’s quarterly earnings would be $6.14, but it ended up being $5.99, beating the consensus by 2.50%. EBITDA was $9.08 billion for the quarter. At the end of UnitedHealth Group Incorporated’s most recent quarter ended June 29, its liabilities totaled 192.8 billion, while its total debt was $65.59 billion. Equity owned by shareholders amounts to $926.3 million.
Technical Picture
Here’s a quick look at UnitedHealth Group Incorporated’s (UNH) price momentum from a technical perspective. As of 14 August, the RSI 9-day stood at 61.87%, suggesting the stock is Neutral, with a 12.13% historical volatility rate.
The stochastic %K and %D were 69.58% and 54.49% respectively, while the average true range (ATR) was 7.86. Based on the 14-day stochastic reading of 77.51%, the RSI (14) reading is 60.61%. On the 9-day MACD Oscillator, the stock is at 3.11, and the 14-day reading is at 3.72.
Analyst Ratings
In a note to investors, UBS maintained its a Neutral rating on UnitedHealth Group Incorporated (NYSE: UNH). However, the firm raised their price target to $520, indicating a possible increase of 0.08% in the stock price. Analysts have assigned UnitedHealth Group Incorporated (UNH) an Buy rating. UNH is a stock that is recommended for selling by 0 brokerage firms, while 4 companies recommend holding. The stock is underweighted by 0 analysts. Among the analysts who rate the stock, 3 rates it overweight and 19 others recommend it as a buy.
What is UNH’s price target for the next 12 months?
The current consensus forecast for the stock is between $520.00 and $650.00, with a median target price of $567.50. In analyzing these forecasts, the average price target given by analysts for UnitedHealth Group Incorporated (UNH) is $572.75.
